Afatinib Dimaleate
Spezifikationen
850140-73-7CAS-Nummer
810-416-1EG-Nummer
bis((Z)-but-2-enedioic acid);(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamideIUPAC-Name
C32H33ClFN5O11Chemische Formel
718.1 g/molMolekulargewicht
AFATINIB DIMALEATE; 850140-73-7; Gilotrif; Afatinib maleate; Giotrif; BIBW 2992MA2; BIBW2992 MA2; BIBW2992-MA2; V1T5K7RZ0B; BIBW-2992MA2; BIBW-2992 MA2; BIBW-2992-MA2; CHEBI:76003; DTXSID701027713; RefChem:56996; BIBW 2992 MA2; DTXCID001513290; (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate); 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-,(2E)-, (2Z)-2-Butenedioate (1:2); Afatinib (diMaleate); Afatinib dimaleate [USAN]; Afatinib maleate (JAN); (S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide dimaleate; Afatinib (BIBW2992) Dimaleate; Afatinib dimaleate (USAN); (Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide; AFATINIB MALEATE [JAN]; C32H33ClFN5O11; MFCD25974239; (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate); UNII-V1T5K7RZ0B; 850140-73-7 (dimaleate); Gilotrif (TN); (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate (1:2) (9CI); Afatinib dimaleate; BIBW 2992MA2; Giotrif (TN); EX-A065B; orb1223861; orb1307469; AFATINIB DIMALEATE [MI]; CHEMBL2105712; SCHEMBL29356586; SCHEMBL29686662; SCHEMBL29838796; USNRYVNRPYXCSP-JUGPPOIOSA-N; AFATINIB DIMALEATE [VANDF]; GLXC-90167; AFATINIB DIMALEATE [WHO-DD]; HY-10261A; AKOS025401819; CCG-270401; CS-1329; AFATINIB DIMALEATE [ORANGE BOOK]; BIBW2992-MA2 (Afatinib dimaleate)?; 1644565-87-6; AC-26080; AS-56967; BA162012; SY059073; D09733; F798908; Q27145677; (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide di[(2Z)-but-2-enedioate]; (E)-4-Dimethylamino-But-2-Enoic Acid-(4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetra-Hydrofuran-3-Yloxy)-Quinazolin-6Yl)-Amide Dimaleate; (E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide;maleic acid; (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide Dimaleate; 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2); 2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2e)-, (2Z)-2-butenedioate (1:2); 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2) (9CI)Synonyme
Produkte, die Afatinib Dimaleate enthalten
지오트립정40밀리그램(아파티닙이말레산염)지오트립정30밀리그램(아파티닙이말레산염)지오트립정20밀리그램(아파티닙이말레산염)GIOTRIF 50 mg, comprimé pelliculéGIOTRIF 40 mg, comprimé pelliculéGIOTRIF 30 mg, comprimé pelliculéGIOTRIF 20 mg, comprimé pelliculéBIBW2992 DiMaleateAfatinib diMaleateAfatinib DiMaleateAfatinib dimaleateAfatinib Dimaleate
Seite 1 von 2
Unternehmen, die Afatinib Dimaleate verkaufen
SF
Shanghai Famo Biotechnology Co.,Ltd.ChinaHD
Hangzhou Dingyan Chem Co., LtdChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaSS
Shandong Sihuan Pharmaceutical Co.,Ltd.ChinaBI
BOEHRINGER INGELHEIM INTERNATIONALFrance한국
한국베링거인겔하임(주)Republic of KoreaBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaAC
AFINE CHEMICALS LIMITED